Aerpio Therapeutics' Series A - II Round

Aerpio Therapeutics raised a round of funding on November 06, 2013.

Aerpio Therapeutics is a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. Aerpio is a leader in the development of small molecule drugs based…

Articles about Aerpio Therapeutics' Series A - II Round: